Pages that link to "Q45901293"

The following pages link to Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. (Q45901293):

Displaying 48 items.

• Peripheral nerve regeneration with sustained release of poly(phosphoester) microencapsulated nerve growth factor within nerve guide conduits (Q28191449) (← links)
• Therapeutic strategies to improve drug delivery across the blood-brain barrier (Q30407443) (← links)
• Process and formulation variables in the preparation of injectable and biodegradable magnetic microspheres (Q30498930) (← links)
• Formulation and release characteristics of poly(lactic-co-glycolic acid) microspheres containing chemically modified protein (Q32019091) (← links)
• Surfactant-free formulation of poly(lactic/glycolic) acid nanoparticles encapsulating functional polypeptide: a technical note (Q33563560) (← links)
• The behavioral and biochemical effects of BDNF containing polymers implanted in the hippocampus of rats (Q33712487) (← links)
• Advances in progenitor cell therapy using scaffolding constructs for central nervous system injury. (Q33870573) (← links)
• Growth factor delivery for tissue engineering (Q33963660) (← links)
• Cell delivery to the central nervous system (Q34003146) (← links)
• Growth factor release from tissue engineering scaffolds. (Q34456378) (← links)
• Biodegradable block copolymers (Q34456732) (← links)
• Biodegradable nanoparticle-entrapped vaccine induces cross-protective immune response against a virulent heterologous respiratory viral infection in pigs (Q34512592) (← links)
• Biomaterials and strategies for nerve regeneration (Q36534279) (← links)
• Inductive tissue engineering with protein and DNA-releasing scaffolds (Q36553094) (← links)
• Use of degradable and nondegradable nanomaterials for controlled release (Q36917951) (← links)
• Growth factor and stem cell enhanced conduits in peripheral nerve regeneration and repair (Q37350123) (← links)
• Biodegradable Elastomers for Tissue Engineering and Cell–Biomaterial Interactions (Q37828112) (← links)
• The use of convection-enhanced delivery with liposomal toxins in neurooncology. (Q37954331) (← links)
• Controlled release of vascular endothelial growth factor using poly-lactic-co-glycolic acid microspheres: in vitro characterization and application in polycaprolactone fumarate nerve conduits (Q38590032) (← links)
• Preparation and evaluation of NGF-microsphere conduits for regeneration of defective nerves (Q39340672) (← links)
• In vivo validation of biological responses of bFGF released from microspheres formulated by blending poly-lactide-co-glycolide and poly(ethylene glycol)-grafted-chitosan in hamster cheek pouch microcirculatory models (Q39849570) (← links)
• Nasal delivery of chitosan-coated poly(lactide-co-glycolide)-encapsulated honeybee (Apis mellifera) venom promotes Th 1-specific systemic and local intestinal immune responses in weaned pigs. (Q40586190) (← links)
• Effects of NFkappaB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line. (Q40726012) (← links)
• Adsorption of a porcine reproductive and respiratory syndrome virus DNA vaccine candidate onto biodegradable nanoparticles improves immunogenicity in mice (Q41067799) (← links)
• Poly D,L-lactide-co-glycolide (PLGA) nanoparticle-encapsulated honeybee (Apis melifera) venom promotes clearance of Salmonella enterica serovar Typhimurium infection in experimentally challenged pigs through the up-regulation of T helper type 1 spec (Q41751896) (← links)
• Novel PEG-graft-PLA nanoparticles with the potential for encapsulation and controlled release of hydrophobic and hydrophilic medications in aqueous medium. (Q42031220) (← links)
• Controlled release of bevacizumab through nanospheres for extended treatment of age-related macular degeneration. (Q42207862) (← links)
• PLA/PEG-PPG-PEG/dexamethasone implant prepared by hot-melt extrusion for controlled release of immunosuppressive drug to implantable medical devices, Part 2: in vivo evaluation (Q43568360) (← links)
• Chitin/PLGA blend microspheres as a biodegradable drug-delivery system: phase-separation, degradation and release behavior (Q44052997) (← links)
• PLGA nanoparticle entrapped killed porcine reproductive and respiratory syndrome virus vaccine helps in viral clearance in pigs (Q44365260) (← links)
• Formulation and characterization of poly(propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles for pH-dependent membrane disruption and cytosolic delivery (Q46640134) (← links)
• An integrated experimental and modeling approach to propose biotinylated PLGA microparticles as versatile targeting vehicles for drug delivery (Q46771378) (← links)
• Fabrication and characterization of microspheres encapsulating astrocytes for neural regeneration (Q47743278) (← links)
• Using biomaterials to modulate chemotactic signaling for central nervous system repair (Q48091188) (← links)
• Targeted Delivery of GP5 Antigen of PRRSV to M Cells Enhances the Antigen-Specific Systemic and Mucosal Immune Responses (Q50031504) (← links)
• The Effect of Aligned Core–Shell Nanofibres Delivering NGF on the Promotion of Sciatic Nerve Regeneration (Q50439130) (← links)
• A hybrid approach for the control of axonal outgrowth: preliminary simulation results (Q50694282) (← links)
• Chitin/PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein (Q51812481) (← links)
• Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles (Q57188403) (← links)
• Biodegradable poly(D,L-lactic acid)-poly(ethylene glycol)-monomethyl ether diblock copolymers: structures and surface properties relevant to their use as biomaterials (Q57188672) (← links)
• Regenerative Strategies for the Central Nervous System (Q57460363) (← links)
• Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles (Q73594312) (← links)
• Defining the concentration gradient of nerve growth factor for guided neurite outgrowth (Q73685855) (← links)
• In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices (Q74082962) (← links)
• Creating porous tubes by centrifugal forces for soft tissue application (Q74418427) (← links)
• Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices (Q77844745) (← links)
• Neural regrowth induced by PLGA nerve conduits and neurotrophin‐3 in rats with complete spinal cord transection (Q83560463) (← links)
• In Situ Hydrogel Formulation for Intra-Articular Application of Diclofenac Sodium-Loaded Polymeric Nanoparticles (Q95851894) (← links)